MD

Michael Daniell

Fisher & Paykel Healthcare Corporation Limited | Non-Executive Director
Mr Daniell has over 40 years' experience in the medical device industry with executive leadership experience. Former Managing Director and CEO of Fisher & Paykel Healthcare Corporation Limited responsible for the global business and operations including the design, manufacture and marketing of innovative products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea.

Companies and Roles

Company
Title
Tenure
Since
FPH
Fisher & Paykel Healthcare Corporation Limited
  • Non-Executive Director
22yrs, 6mthNov 2001
COH
Cochlear Limited
  • Non-Executive Director
4yrs, 4mthJan 2020

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
COH
Cochlear Limited
17/08/23N/A1,614N/AN/A
FPH
Fisher & Paykel Healthcare Corporation Limited
31/03/23N/A900,168N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
COH
Cochlear Limited
17/08/23
Buy
200$246.910$49,382On-market trade
COH
Cochlear Limited
24/08/22
Buy
200$215.180$43,036On-market trade
FPH
Fisher & Paykel Healthcare Corporation Limited
02/07/20
Issued
15,901$35.281$561,004Issue of securities
FPH
Fisher & Paykel Healthcare Corporation Limited
02/07/20
Cancelled
20,000$32.400$648,000Cancellation of securities
FPH
Fisher & Paykel Healthcare Corporation Limited
01/07/20
Sell
90,000$34.269$3,084,209As advised by the company